Tyme Technologies Shares Outstanding 2012-2018 | TYME

Tyme Technologies shares outstanding history from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Tyme Technologies shares outstanding for the quarter ending June 30, 2018 were 0.101B, a 13.41% increase year-over-year.
  • Tyme Technologies 2018 shares outstanding were 0.091B, a 7.24% increase from 2017.
  • Tyme Technologies 2017 shares outstanding were 0.084B, a INF% increase from 2016.
  • Tyme Technologies 2016 shares outstanding were 0B, a 100% decline from 2015.
Tyme Technologies Annual Shares Outstanding
(Millions of Shares)
2018 91
2017 84
2016 0
2015 78
2014 68
2014 52
2014 0
2013 52
2013 0
2012 11
2011 9
Tyme Technologies Quarterly Shares Outstanding
(Millions of Shares)
Q1 2018 101
Q4 2018 91
Q3 2017 90
Q2 2017 89
Q1 2017 89
Q4 2017 84
Q3 2016 85
Q2 2016 84
Q1 2016 84
Q4 2016 84
Q3 2015 0
Q2 2015 86
Q1 2015 86
Q4 2015 73
Q4 2015 52
Q3 2014 0
Q3 2014 0
Q2 2014 68
Q2 2014 52
Q1 2014 68
Q1 2014 12
Q4 2014 68
Q4 2014 52
Q3 2013 0
Q3 2013 0
Q2 2013 52
Q1 2013 12
Q4 2013 12
Q3 2012 0
Q2 2012 12
Q1 2012 11
Q4 2012 9
Q3 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.241B $0.000B
Tyme Technologies, Inc. is a pharmaceutical company. The company is focused on creating medicines which specialize in the body's immune system to treat diseases. Tyme Technologies, Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.195B 11.27
Zoetis (ZTS) United States $44.072B 31.98
Tilray (TLRY) United States $13.534B 0.00
Grifols (GRFS) Spain $13.213B 16.13
Neurocrine Biosciences (NBIX) United States $10.133B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.423B 13.87
Nektar Therapeutics (NKTR) United States $8.311B 9.72
Ionis Pharmaceuticals (IONS) United States $6.203B 0.00
Catalent (CTLT) United States $6.007B 25.86
Sage Therapeutics (SAGE) United States $5.708B 0.00
Impax Laboratories (AMRX) United States $5.590B 0.00
United Therapeutics (UTHR) United States $5.356B 6.88
Loxo Oncology (LOXO) United States $4.875B 0.00
FibroGen (FGEN) United States $4.461B 0.00
Endo (ENDP) Ireland $3.926B 5.64
Taro Pharmaceutical Industries (TARO) Israel $3.745B 14.50
Madrigal Pharmaceuticals (MDGL) United States $2.958B 0.00
Aerie Pharmaceuticals (AERI) United States $2.640B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.559B 0.00
USANA Health Sciences (USNA) United States $2.532B 22.31
TESARO (TSRO) United States $2.293B 0.00
Heron Therapeutics (HRTX) United States $2.264B 0.00
Xencor (XNCR) United States $1.955B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.925B 0.00
PTC Therapeutics (PTCT) United States $1.910B 0.00
Endocyte (ECYT) United States $1.651B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.605B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.530B 18.71
Zogenix (ZGNX) United States $1.488B 0.00
Portola Pharmaceuticals (PTLA) United States $1.448B 0.00
Corcept Therapeutics (CORT) United States $1.412B 21.73
Spectrum Pharmaceuticals (SPPI) United States $1.397B 0.00
TherapeuticsMD (TXMD) United States $1.269B 0.00
Tricida (TCDA) United States $1.265B 0.00
Esperion Therapeutics (ESPR) United States $1.206B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.149B 0.00
ImmunoGen (IMGN) United States $1.107B 0.00
Radius Health (RDUS) United States $0.862B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.785B 0.00
Karyopharm Therapeutics (KPTI) United States $0.743B 0.00
Flexion Therapeutics (FLXN) United States $0.716B 0.00
GlycoMimetics (GLYC) United States $0.609B 0.00
Dova Pharmaceuticals (DOVA) United States $0.582B 0.00
ChemoCentryx (CCXI) United States $0.574B 33.56
Dermira (DERM) United States $0.550B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.549B 0.00
Collegium Pharmaceutical (COLL) United States $0.545B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.496B 0.00
Akebia Therapeutics (AKBA) United States $0.492B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.474B 0.00
ArQule (ARQL) United States $0.470B 0.00
OptiNose (OPTN) United States $0.470B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.456B 31.09
Forty Seven (FTSV) United States $0.451B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.424B 0.00
Xeris Pharmaceuticals (XERS) United States $0.415B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.415B 0.00
Odonate Therapeutics (ODT) United States $0.411B 0.00
Minerva Neurosciences (NERV) United States $0.410B 0.00
Siga Technologies (SIGA) United States $0.401B 0.00
Aclaris Therapeutics (ACRS) United States $0.387B 0.00
Zafgen (ZFGN) United States $0.382B 0.00
Depomed (ASRT) United States $0.368B 0.00
Aquestive Therapeutics (AQST) United States $0.358B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.354B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.352B 0.00
Concert Pharmaceuticals (CNCE) United States $0.347B 0.00
ElectroCore (ECOR) United States $0.341B 0.00
KalVista Pharmaceuticals (KALV) United States $0.340B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.340B 0.00
Mast Therapeutics (SVRA) United States $0.333B 0.00
Majesco Entertainment (PTE) United States $0.275B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.270B 0.00
MEI Pharma (MEIP) United States $0.267B 0.00
CASI Pharmaceuticals (CASI) United States $0.265B 0.00
Translate Bio (TBIO) United States $0.263B 0.00
Aratana Therapeutics (PETX) United States $0.256B 0.00
IMV INC (IMV) Canada $0.252B 0.00
Neon Therapeutics (NTGN) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Opexa Therapeutics (ACER) United States $0.246B 0.00
Ardelyx (ARDX) United States $0.241B 0.00
Ocular Therapeutix (OCUL) United States $0.238B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.232B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.225B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.220B 0.00
Melinta Therapeutics (MLNT) United States $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.202B 0.00
Affimed (AFMD) Germany $0.200B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.182B 0.00
Achaogen (AKAO) United States $0.181B 0.00
Redhill Biopharma (RDHL) Israel $0.179B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
Molecular Templates (MTEM) United States $0.171B 0.00
DURECT (DRRX) United States $0.168B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Nature's Sunshine Products (NATR) United States $0.159B 0.00
ContraFect (CFRX) United States $0.152B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.151B 0.00
Lannett Co Inc (LCI) United States $0.151B 1.25
Recro Pharma (REPH) United States $0.150B 0.00
Infinity Pharmaceuticals (INFI) United States $0.145B 0.00
Adherex Technologies (FENC) United States $0.143B 0.00
Champions Oncology (CSBR) United States $0.143B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.139B 0.00
ProNAi Therapeutics (SRRA) Canada $0.132B 0.00
Neos Therapeutics (NEOS) United States $0.123B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.123B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
CTI BioPharma (CTIC) United States $0.112B 0.00
BioLineRx (BLRX) Israel $0.104B 0.00
Forward Pharma (FWP) Denmark $0.100B 0.00
ENTASIS THERAPT (ETTX) United States $0.097B 0.00
Iterum Therapeutics (ITRM) Ireland $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 0.00
Immune Design (IMDZ) United States $0.080B 0.00
Otonomy (OTIC) United States $0.080B 0.00
Natural Alternatives (NAII) United States $0.071B 7.95
Nivalis Therapeutics (ALPN) United States $0.069B 0.00
Novan (NOVN) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
Trillium Therapeutics (TRIL) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.048B 25.30
KemPharm (KMPH) United States $0.040B 0.00
Capnia (SLNO) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.039B 0.00
Avenue Therapeutics (ATXI) United States $0.038B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 9.40
Lipocine (LPCN) United States $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.025B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Shineco (TYHT) China $0.018B 1.81
Aradigm (ARDM) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Midatech Pharma (MTP) United Kingdom $0.016B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.014B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Pain Therapeutics (PTIE) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
PharmAthene (ALT) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00